|
LY-2881835
|
DB15046 |
[LY-2881835 is under investigation in clinical trial NCT01358981 (A Study of LY2881835 in Healthy People and People With Diabetes).] |
|
Licogliflozin
|
DB15048 |
[Licogliflozin is under investigation in clinical trial NCT03320941 (A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity).] |
|
Toripalimab
|
DB15043 |
[Toripalimab is under investigation in clinical trial NCT03919383 (Phase II of Lenvatinib Plus Toripalimab for Advanced HCC).] |
|
Tavolixizumab
|
DB15042 |
[Tavolixizumab is under investigation in clinical trial NCT02318394 (A Phase 1 Study of MEDI0562 in Adult Subjects With Selected Advanced Solid Tumors).] |
|
Ipafricept
|
DB15045 |
[Ipafricept is under investigation in clinical trial NCT01608867 (A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors).] |
|
Tafasitamab
|
DB15044 |
[Tafasitamab is under investigation in clinical trial NCT02005289 (Phase II MOR00208 in Combination With Lenalidomide for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL).] |
|
Florilglutamic acid F-18
|
DB15041 |
[Florilglutamic acid F-18 is under investigation in clinical trial NCT02370563 (PET Imaging of Intracranial Cancers With 18F-FSPG).] |
|
TP-271
|
DB15040 |
[TP-271 is under investigation in clinical trial NCT02724085 (A Phase 1 Study to Assess the Safety, Tolerability and PK of IV TP-271).] |
|
Cytidine-5'-diphospho-beta-D-xylose
|
DB03069 |
|
|
Lactic acid
|
DB04398 |
[A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed) Sodium lactate is the sodium salt of lactic acid, and has a mild saline taste. It is produced by fermentation of a sugar source, such as corn or beets, and then, by neutralizing the resulting lactic acid to create a compound having the formula NaC3H5O3.] |
|
4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid
|
DB03067 |
|
|
Zebularine
|
DB03068 |
[A chemically stable, cytidine analog that displays anti-tumor properties. It acts as a transition state analog inhibitor of cytidine deaminase by binding to the active site as covalent hydrates. Also shown to inhibit DNA methylation and tumor growth both in vitro and in vivo.] |
|
3-[[(3R,4S,5S,6R)-7-Benzyl-4,5-dihydroxy-1,1-dioxo-3,6-bis(phenoxymethyl)-1,2,7-thiadiazepan-2-yl]methyl]-N-methylbenzamide
|
DB03076 |
|
|
3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione
|
DB03077 |
|
|
7-cyano-7-deazaguanine
|
DB03074 |
|
|
(Diphosphono)Aminophosphonic Acid
|
DB03075 |
|
|
2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone
|
DB03072 |
|
|
3-Methoxybenzamide
|
DB03073 |
|
|
Selenazole-4-carboxyamide-adenine dinucleotide
|
DB03070 |
|
|
4-Methylidene-5-One
|
DB03071 |
|
